Third generation oral contraception and venous thromboembolism.
作者信息
McPherson K
出版信息
BMJ. 1996 Jan 13;312(7023):68-9. doi: 10.1136/bmj.312.7023.68.
Abstract
摘要
相似文献
1
Third generation oral contraception and venous thromboembolism.第三代口服避孕药与静脉血栓栓塞症
BMJ. 1996 Jan 13;312(7023):68-9. doi: 10.1136/bmj.312.7023.68.
2
Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.第三代口服避孕药与心肌梗死风险：一项国际病例对照研究。口服避孕药与年轻女性健康跨国研究小组。
BMJ. 1996 Jan 13;312(7023):88-90. doi: 10.1136/bmj.312.7023.88.
3
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.第三代口服避孕药与静脉血栓栓塞性疾病风险：一项国际病例对照研究。口服避孕药与年轻女性健康跨国研究小组。
BMJ. 1996 Jan 13;312(7023):83-8. doi: 10.1136/bmj.312.7023.83.
4
Scare over oral contraceptives. Was Committee on Safety of Medicines' advice arrived at lawfully?口服避孕药恐慌。药品安全委员会的建议是合法得出的吗？
BMJ. 1995 Dec 16;311(7020):1640. doi: 10.1136/bmj.311.7020.1640.
5
A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.
Int J Fertil Womens Med. 1997 Jul-Aug;42(4):230-9.
6
Oral contraception and venous thromboembolism. A New Zealand perspective.
Drug Saf. 1997 Feb;16(2):79-87. doi: 10.2165/00002018-199716020-00001.
7
Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications.具有治疗适应症的口服孕激素制剂与心血管疾病的风险。
Lancet. 1999 Nov 6;354(9190):1610. doi: 10.1016/s0140-6736(99)03132-3.
8
Scare over oral contraceptives. Committee's action will undermine further research and development.对口服避孕药的恐慌。委员会的行动将破坏进一步的研发。
BMJ. 1995 Dec 16;311(7020):1639-40. doi: 10.1136/bmj.311.7020.1639c.
9
10
[Third-generation oral contraceptives--how big is the risk of venous thrombosis?].[第三代口服避孕药——静脉血栓形成的风险有多大？]
Tidsskr Nor Laegeforen. 2004 Jun 3;124(11):1521-2.
引用本文的文献
1
Symmetrical analysis of risk-benefit.风险效益对称分析。
Br J Clin Pharmacol. 2012 Nov;74(5):757-61. doi: 10.1111/j.1365-2125.2012.04265.x.
2
3
Mortality from venous thromboembolism among young women in Europe: no evidence for any effect of third generation oral contraceptives.欧洲年轻女性静脉血栓栓塞的死亡率：无证据表明第三代口服避孕药有任何影响。
J Epidemiol Community Health. 1997 Dec;51(6):630-5. doi: 10.1136/jech.51.6.630.
4
Evidence-based medicine and general practice.循证医学与全科医学
Br J Gen Pract. 1997 Jul;47(420):449-52.
5
The statistical basis of public policy: a paradigm shift is overdue.公共政策的统计基础：范式转变刻不容缓。
BMJ. 1996 Sep 7;313(7057):603-7. doi: 10.1136/bmj.313.7057.603.
6
Third generation oral contraceptives. 12% of women stopped taking their pill immediately they heart CSM's warning.第三代口服避孕药。12%的女性在听到药品安全委员会的警告后立即停止服用避孕药。
BMJ. 1996 Mar 2;312(7030):576. doi: 10.1136/bmj.312.7030.576b.
本文引用的文献
1
Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.第三代口服避孕药与心肌梗死风险：一项国际病例对照研究。口服避孕药与年轻女性健康跨国研究小组。
BMJ. 1996 Jan 13;312(7023):88-90. doi: 10.1136/bmj.312.7023.88.
2
Smoking and death: the past 40 years and the next 40.吸烟与死亡：过去40年及未来40年
BMJ. 1994 Oct 8;309(6959):937-9. doi: 10.1136/bmj.309.6959.937.
3
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.携带第三代孕激素的口服避孕药所致深静脉血栓形成风险因凝血因子V莱顿突变而增加。
Lancet. 1995 Dec 16;346(8990):1593-6. doi: 10.1016/s0140-6736(95)91929-5.
4
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.使用含不同孕激素成分口服避孕药的女性发生特发性心血管死亡和非致命性静脉血栓栓塞的风险。
Lancet. 1995 Dec 16;346(8990):1589-93. doi: 10.1016/s0140-6736(95)91928-7.
5
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.低雌激素口服避孕药中不同孕激素对静脉血栓栓塞性疾病的影响。世界卫生组织心血管疾病与甾体激素避孕协作研究。
Lancet. 1995 Dec 16;346(8990):1582-8.
6
Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.静脉血栓栓塞性疾病与复方口服避孕药：国际多中心病例对照研究结果。世界卫生组织心血管疾病与甾体激素避孕协作研究。
Lancet. 1995 Dec 16;346(8990):1575-82.
7
Oral contraceptives and cardiovascular disease (first of two parts).口服避孕药与心血管疾病（两部分中的第一部分）
N Engl J Med. 1981 Sep 10;305(11):612-8. doi: 10.1056/NEJM198109103051104.
Zotero 插件